美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Sanofi

0.8711

0.0000

成交量：- -

成交額：- -

市值：10.92億

市盈率：0.35

高：0.8711

開：0.8711

低：0.8711

收：0.8711

資料載入中...

總覽公司新聞公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞

賽默飛世爾科技將收購賽諾菲位於新澤西州里奇菲爾德的無菌製造工廠Thermo Fisher Scientific to Acquire Sanofi’s Sterile Manufacturing Facility in Ridgefield, New Jersey

印度 Emcure與賽諾菲簽署口服抗糖尿病產品分銷協議Emcure, Sanofi ink distribution pact for oral anti-diabetic products in India

美國OTC市場Sanofi盤中異動股價大跌5.08%報94.35美元

賽諾菲將於第三季度開始全球運送Beyfortus RSV預防治療藥物Sanofi to Begin Global Shipments of Beyfortus RSV Prevention Treatment in Third Quarter

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/GCVRZ"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GCVRZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GCVRZ\",,,,,undefined,":{"symbol":"GCVRZ","market":"US","secType":"STK","nameCN":"Sanofi","latestPrice":0.8711,"timestamp":1583269200000,"preClose":0.8711,"halted":3,"volume":0,"delay":0,"floatShares":1114622547,"shares":1254041488,"eps":2.519335,"marketStatus":"停牌","change":0,"latestTime":"03-03 16:00:00 EST","open":0.8711,"high":0.8711,"low":0.8711,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.519335,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.8711,"dividendRate":4.027632,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GCVRZ\",,,,,undefined,":{"symbol":"GCVRZ","floatShares":1114622547,"roa":"4.03%","roe":"4.97%","lyrEps":2.519335,"shares":1254041488,"dividePrice":3.664379,"high":0.8711,"amplitude":0,"preClose":0.8711,"low":0.8711,"week52Low":0.34,"pbRate":"0.02","week52High":0.882,"institutionHeld":0.1803,"latestPrice":0.8711,"eps":2.519335,"divideRate":4.206611,"volume":0,"delay":0,"ttmEps":2.519335,"open":0.8711,"prevYearClose":0.8602},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GCVRZ\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GCVRZ\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552867884","title":"賽默飛世爾科技將收購賽諾菲位於新澤西州里奇菲爾德的無菌製造工廠Thermo Fisher Scientific to Acquire Sanofi’s Sterile Manufacturing Facility in Ridgefield, New Jersey","url":"https://stock-news.laohu8.com/highlight/detail?id=2552867884","media":"动脉网","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552867884?lang=zh_tw&edition=fundamental","pubTime":"2025-07-17 18:09","pubTimestamp":1752746940,"startTime":"0","endTime":"0","summary":"by Mark Chiang马克·蒋Share To分享到Thermo Fisher Scientific has entered into an agreement to acquire Sanofi’s sterile manufacturing facility located in Ridgefield, New Jersey. The deal, announced on July 17, 2025, marks a significant development in the pharmaceutical manufacturing sector.赛默飞世尔科技已达成协议，收购位于新泽西州里奇菲尔德的赛诺菲无菌制造工厂。The Ridgefield site specializes in the production of sterile injectable medicines and is expected to enhance Thermo Fisher’s capabilities in this area. The acquisition aligns with Thermo Fisher’s ongoing efforts to expand its pharmaceutical services network and meet growing demand for sterile drug products.里奇菲尔德工厂专注于无菌注射药物的生产，预计将增强赛默飞世尔在这一领域的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717181121954602bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717181121954602bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2468319806.SGD","LU0011850046.USD","IE00BJT1NW94.SGD","LU1548497426.USD","IE00B1BXHZ80.USD","TMO","IE00B2B36J28.USD","GCVRZ","LU0316494557.USD","LU0342679015.USD","BK4548","LU2092937221.SGD","LU1670628061.USD","LU2125910179.SGD","LU2298321311.HKD","GB00BDT5M118.USD","LU1633808545.USD","LU1989771016.USD","LU0122379950.USD","LU1023059063.AUD","LU1670627923.USD","LU0234572021.USD","LU1057294990.SGD","LU1720051017.SGD","LU1815333072.USD","LU1923621640.USD","LU1983299246.USD","LU2764263203.CNY","IE00B19Z9505.USD","SNYNF","BK4534","LU2125909916.SGD","SNY","LU1153585028.USD","LU0557290698.USD","LU1988902786.USD","IE00B19Z8W00.USD","LU2211814178.USD","LU2433249047.HKD","LU2112291526.USD","LU0957791311.USD","LU2125909593.SGD","LU2357305700.SGD","LU1280957306.USD","LU2089984988.USD","LU0528227936.USD","BK4581","IE00B4R5TH58.HKD","LU1061106388.HKD","BK4533"],"gpt_icon":0},{"id":"2551527125","title":"印度 Emcure與賽諾菲簽署口服抗糖尿病產品分銷協議Emcure, Sanofi ink distribution pact for oral anti-diabetic products in India","url":"https://stock-news.laohu8.com/highlight/detail?id=2551527125","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551527125?lang=zh_tw&edition=fundamental","pubTime":"2025-07-16 20:56","pubTimestamp":1752670560,"startTime":"0","endTime":"0","summary":"Emcure Pharmaceuticals埃姆库尔制药公司Ltd and有限公司和Sanofi India赛诺菲印度Ltd on Wednesday said they have entered into an exclusive distribution and promotion agreement for the latter's有限公司在周三表示，他们已经就后者的产品签订了独家分销和推广协议。oral anti-diabetic products口服抗糖尿病产品in India with immediate effect.在印度立即生效。Under the agreement, Emcure will exclusively distribute and promote Sanofi India's OAD  range of products that include brands like Amaryl and Cetapin, the two companies said in a joint statement.根据协议，Emcure将独家分销并推广赛诺菲印度的OAD系列产品，包括Amaryl和Cetapin等品牌，两家公司在联合声明中表示。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162057159544e208&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162057159544e208&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GCVRZ","IE00BFXG1179.USD","BK4585","BK4007","SNYNF","SNY","BK4588"],"gpt_icon":0},{"id":"2551193109","title":"美國OTC市場Sanofi盤中異動 股價大跌5.08%報94.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551193109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551193109?lang=zh_tw&edition=fundamental","pubTime":"2025-07-15 22:46","pubTimestamp":1752590761,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日22时46分，美国OTC市场Sanofi股票出现波动，股价急速跳水5.08%。截至发稿，该股报94.35美元/股，成交量486股，换手率0.00%，振幅0.00%。美国OTC市场Sanofi股票所在的制药行业中，整体跌幅为1.42%。美国OTC市场Sanofi公司简介：赛诺菲专注于疫苗、免疫学、肿瘤学、心血管疾病、糖尿病和非处方治疗药物的开发和销售。超过40%的总收入来自美国，25%来自欧洲。新兴市场占据了剩余收入的大部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715224601a44cac37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715224601a44cac37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNYNF","GCVRZ","BK4007"],"gpt_icon":0},{"id":"2545100384","title":"賽諾菲將於第三季度開始全球運送Beyfortus RSV預防治療藥物Sanofi to Begin Global Shipments of Beyfortus RSV Prevention Treatment in Third Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2545100384","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545100384?lang=zh_tw&edition=fundamental","pubTime":"2025-06-21 14:06","pubTimestamp":1750485960,"startTime":"0","endTime":"0","summary":"The decision comes as part of Sanofi’s strategy to ensure timely availability of Beyfortus, particularly during a period when demand for RSV prevention typically increases. By initiating shipments in Q3, the company aims to support healthcare systems worldwide in preparing for the seasonal rise in RSV cases.该决定是赛诺菲确保 Beyfortus 及时供应战略的一部分，尤其是在对 RSV 预防需求通常增加的时期。通过在第三季度开始发货，该公司旨在支持全球医疗系统为 RSV 病例的季节性增长做好准备。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621140922952592c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621140922952592c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNY","BK4585","BK4007","SNYNF","BK4588","IE00BFXG1179.USD","GCVRZ"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GCVRZ\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GCVRZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GCVRZ\",market:\"US\",delay:false,,,undefined,":{}}}